Predicting risk of progression in relapsed multiple myeloma using traditional risk models, focal lesion assessment with PET-CT and minimal residual disease status.
Baker D, Bimali M, Carrillo L, Sachedina A, Alapat D, Hoque MS, Kottarathara M, Parikh R, Erra A, Mitma AA, Mathur P, Ogunsesan Y, Yarlagadda L, Gundarlapalli S, Thanendrarajan S, Zangari M, Van Rhee F, Tricot G, Schinke C.
Baker D, et al. Among authors: sachedina a.
Haematologica. 2021 Dec 1;106(12):3215-3218. doi: 10.3324/haematol.2021.278779.
Haematologica. 2021.
PMID: 34847659
Free PMC article.
No abstract available.